• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IDT
Click for more information
4.76% 10.0¢

IDT AUSTRALIA LIMITED - Announcements

Market Cap $51.58M  ! watchlist Created with Sketch. Add to my watchlist

IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged... IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IDT Appendix 3B28/04/15
IDT Update-Generic product acquisition and integrationPRICE SENSITIVE13/04/15
IDT Updated Investor Presentation05/03/15
IDT Cancellation of shares23/02/15
IDT Half Yearly Report and Accounts17/02/15
IDT Half Year AccountsPRICE SENSITIVE17/02/15
IDT Becoming a substantial holder02/02/15
IDT +Becoming a substantial holder from AEF - Correction02/01/15
IDT Change in substantial holding30/12/14
IDT +Becoming a substantial holder from AEF29/12/14
IDT Change of Director's Interest Notices24/12/14
IDT Appendix 3B24/12/14
IDT Change of Director's Interest Notice23/12/14
IDT Ceasing to be a substantial holder23/12/14
IDT Ceasing to be a substantial holder23/12/14
IDT Ceasing to be a substantial holder23/12/14
IDT Cleansing notice18/12/14
IDT Appendix 3B18/12/14
IDT Acquisition 23 US Generic Drugs completedPRICE SENSITIVE18/12/14
IDT Correction - Share Purchase Plan - Date Extension16/12/14
IDT Share Purchase Plan - Date Extension15/12/14
IDT Results of Meeting11/12/14
IDT Share Purchase Plan10/11/14
IDT Cleansing Notice10/11/14
IDT Notice of Extraordinary General Meeting10/11/14
IDT Investor Information regarding ANDA Acquisitions06/11/14
IDT Reinstatement to Official QuotationPRICE SENSITIVE03/11/14
IDT IDT to Acquire 23 US Generic Drug ProductsPRICE SENSITIVE03/11/14
IDT Extension of Voluntary Suspension03/11/14
IDT Suspension from Official QuotationPRICE SENSITIVE30/10/14
IDT Request for Voluntary Suspension30/10/14
IDT Trading HaltPRICE SENSITIVE28/10/14
IDT Appendix 3B24/10/14
IDT Results of Meeting23/10/14
IDT Investor Presentation22/10/14
IDT Annual Report to shareholders19/09/14
IDT Notice of Annual General Meeting/Proxy Form19/09/14
IDT Preliminary Final ReportPRICE SENSITIVE20/08/14
IDT US product distributionPRICE SENSITIVE29/07/14
IDTChange of Share Registry26/05/14
IDTCleansing Notice15/05/14
IDTAppendix 3B15/05/14
IDTCompany Secretary Appointment/Resignation18/03/14
IDTHalf Year Accounts20/02/14
IDTAppendix 4DPRICE SENSITIVE20/02/14
IDTIDT secures Option to acquire HRT Product FilingPRICE SENSITIVE28/01/14
IDTResults of Meeting20/11/13
IDTFinal Director's Interest Notice20/11/13
IDTDirector Resignation20/11/13
IDTManaging Director's AGM presentation20/11/13
IDTChairman's Address to Shareholders20/11/13
IDTIDT files ANDA for Temozolomide in the USPRICE SENSITIVE18/11/13
IDTInvestor Presentation Australia Biotech Invest 2013.28/10/13
IDTChange in substantial holding25/10/13
IDTChange of Director's Interest Notice22/10/13
IDTChange of Director's Interest Notice22/10/13
IDTChange in substantial holding22/10/13
IDTChange in substantial holding21/10/13
IDTChange in substantial holding21/10/13
IDTNotice of Annual General Meeting/Proxy Form21/10/13
IDTAppendix 3B18/10/13
IDTNotice under sec708(5)(e) of the Corporations Act 200117/10/13
IDTPlacement completion17/10/13
IDTResults of Meeting09/10/13
IDTChange of Director's Interest Notice02/10/13
IDTChange of Director's Interest Notice02/10/13
IDTAllotment and issue of rights issue securities01/10/13
IDTRights Issue Shortfall Notice27/09/13
IDTAnnual Report to shareholders24/09/13
IDTNotice of General Meeting/Proxy Form06/09/13
IDTLetter to eligible shareholders re Rights Issue02/09/13
IDTRights Issue Offer BookletPRICE SENSITIVE30/08/13
IDTPreliminary Final ReportPRICE SENSITIVE29/08/13
IDTAppendix 3B29/08/13
IDTNon renounceable Rights Issue & PlacementPRICE SENSITIVE29/08/13
IDTCleansing Statement under S708AA29/08/13
IDTTrading HaltPRICE SENSITIVE27/08/13
IDTBoard Changes and Renewal22/08/13
IDTInvestor Presentation 16th August 201316/08/13
IDTAppendix 3B14/08/13
IDTBusiness UpdatePRICE SENSITIVE09/07/13
IDT +Progress on Linguet Ibuprofen formulationPRICE SENSITIVE02/07/13
IDTFinal Director's Interest Notice01/07/13
IDTFinal Director's Interest Notice01/07/13
IDTInitial Director's Interest Notice03/06/13
IDTInitial Director's Interest Notice03/06/13
IDTIDT Australia Restructures Board for Growth22/05/13
IDTBecoming a substantial holder16/05/13
IDTAppendix 3B10/05/13
IDTNotice under Section 708A(5)(e) of the Corporations Act 200110/05/13
IDTCompletion of Placement to I'rom Holdings Co., Ltd10/05/13
IDTStrategic PlacementPRICE SENSITIVE07/05/13
IDTAppendix 3B16/04/13
IDTBusiness UpdatePRICE SENSITIVE16/04/13
IDTFinal Director's Interest Notice01/03/13
IDTHalf Year Accounts26/02/13
IDTHalf Yearly Report and AccountsPRICE SENSITIVE26/02/13
IDTManaging Director's resignationPRICE SENSITIVE14/12/12
IDTResults of Meeting20/11/12
IDTChairman's and Managing Director's AGM presentation20/11/12
IDT Appendix 3B
28/04/15
IDT Update-Generic product acquisition and integration
13/04/15PRICE SENSITIVE
IDT Updated Investor Presentation
05/03/15
IDT Cancellation of shares
23/02/15
IDT Half Yearly Report and Accounts
17/02/15
IDT Half Year Accounts
17/02/15PRICE SENSITIVE
IDT Becoming a substantial holder
02/02/15
IDT +Becoming a substantial holder from AEF - Correction
02/01/15
IDT Change in substantial holding
30/12/14
IDT +Becoming a substantial holder from AEF
29/12/14
IDT Change of Director's Interest Notices
24/12/14
IDT Appendix 3B
24/12/14
IDT Change of Director's Interest Notice
23/12/14
IDT Ceasing to be a substantial holder
23/12/14
IDT Ceasing to be a substantial holder
23/12/14
IDT Ceasing to be a substantial holder
23/12/14
IDT Cleansing notice
18/12/14
IDT Appendix 3B
18/12/14
IDT Acquisition 23 US Generic Drugs completed
18/12/14PRICE SENSITIVE
IDT Correction - Share Purchase Plan - Date Extension
16/12/14
IDT Share Purchase Plan - Date Extension
15/12/14
IDT Results of Meeting
11/12/14
IDT Share Purchase Plan
10/11/14
IDT Cleansing Notice
10/11/14
IDT Notice of Extraordinary General Meeting
10/11/14
IDT Investor Information regarding ANDA Acquisitions
06/11/14
IDT Reinstatement to Official Quotation
03/11/14PRICE SENSITIVE
IDT IDT to Acquire 23 US Generic Drug Products
03/11/14PRICE SENSITIVE
IDT Extension of Voluntary Suspension
03/11/14
IDT Suspension from Official Quotation
30/10/14PRICE SENSITIVE
IDT Request for Voluntary Suspension
30/10/14
IDT Trading Halt
28/10/14PRICE SENSITIVE
IDT Appendix 3B
24/10/14
IDT Results of Meeting
23/10/14
IDT Investor Presentation
22/10/14
IDT Annual Report to shareholders
19/09/14
IDT Notice of Annual General Meeting/Proxy Form
19/09/14
IDT Preliminary Final Report
20/08/14PRICE SENSITIVE
IDT US product distribution
29/07/14PRICE SENSITIVE
IDTChange of Share Registry
26/05/14
IDTCleansing Notice
15/05/14
IDTAppendix 3B
15/05/14
IDTCompany Secretary Appointment/Resignation
18/03/14
IDTHalf Year Accounts
20/02/14
IDTAppendix 4D
20/02/14PRICE SENSITIVE
IDTIDT secures Option to acquire HRT Product Filing
28/01/14PRICE SENSITIVE
IDTResults of Meeting
20/11/13
IDTFinal Director's Interest Notice
20/11/13
IDTDirector Resignation
20/11/13
IDTManaging Director's AGM presentation
20/11/13
IDTChairman's Address to Shareholders
20/11/13
IDTIDT files ANDA for Temozolomide in the US
18/11/13PRICE SENSITIVE
IDTInvestor Presentation Australia Biotech Invest 2013.
28/10/13
IDTChange in substantial holding
25/10/13
IDTChange of Director's Interest Notice
22/10/13
IDTChange of Director's Interest Notice
22/10/13
IDTChange in substantial holding
22/10/13
IDTChange in substantial holding
21/10/13
IDTChange in substantial holding
21/10/13
IDTNotice of Annual General Meeting/Proxy Form
21/10/13
IDTAppendix 3B
18/10/13
IDTNotice under sec708(5)(e) of the Corporations Act 2001
17/10/13
IDTPlacement completion
17/10/13
IDTResults of Meeting
09/10/13
IDTChange of Director's Interest Notice
02/10/13
IDTChange of Director's Interest Notice
02/10/13
IDTAllotment and issue of rights issue securities
01/10/13
IDTRights Issue Shortfall Notice
27/09/13
IDTAnnual Report to shareholders
24/09/13
IDTNotice of General Meeting/Proxy Form
06/09/13
IDTLetter to eligible shareholders re Rights Issue
02/09/13
IDTRights Issue Offer Booklet
30/08/13PRICE SENSITIVE
IDTPreliminary Final Report
29/08/13PRICE SENSITIVE
IDTAppendix 3B
29/08/13
IDTNon renounceable Rights Issue & Placement
29/08/13PRICE SENSITIVE
IDTCleansing Statement under S708AA
29/08/13
IDTTrading Halt
27/08/13PRICE SENSITIVE
IDTBoard Changes and Renewal
22/08/13
IDTInvestor Presentation 16th August 2013
16/08/13
IDTAppendix 3B
14/08/13
IDTBusiness Update
09/07/13PRICE SENSITIVE
IDT +Progress on Linguet Ibuprofen formulation
02/07/13PRICE SENSITIVE
IDTFinal Director's Interest Notice
01/07/13
IDTFinal Director's Interest Notice
01/07/13
IDTInitial Director's Interest Notice
03/06/13
IDTInitial Director's Interest Notice
03/06/13
IDTIDT Australia Restructures Board for Growth
22/05/13
IDTBecoming a substantial holder
16/05/13
IDTAppendix 3B
10/05/13
IDTNotice under Section 708A(5)(e) of the Corporations Act 2001
10/05/13
IDTCompletion of Placement to I'rom Holdings Co., Ltd
10/05/13
IDTStrategic Placement
07/05/13PRICE SENSITIVE
IDTAppendix 3B
16/04/13
IDTBusiness Update
16/04/13PRICE SENSITIVE
IDTFinal Director's Interest Notice
01/03/13
IDTHalf Year Accounts
26/02/13
IDTHalf Yearly Report and Accounts
26/02/13PRICE SENSITIVE
IDTManaging Director's resignation
14/12/12PRICE SENSITIVE
IDTResults of Meeting
20/11/12
IDTChairman's and Managing Director's AGM presentation
20/11/12
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
10.0¢ 		Change
-0.005(4.76%) 		Mkt cap ! $51.58M
Open High Low Value Volume
10.5¢ 10.5¢ 9.9¢ $5.546K 55.41K

Buyers (Bids)

No. Vol. Price($)
3 105019 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 447447 4
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
10.0¢ 		  Change
-0.005 ( 4.76 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 14966
Last updated 15.59pm 21/11/2024 ?
IDT (ASX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.